Jerry Molitor
Expertise in
12
conditions

Dr. Jerry Molitor

Rheumatology
14500 99th Avenue North, 
Maple Grove, MN 
Accepting New Patients
Offers Telehealth
Expertise in
12
conditions
14500 99th Avenue North, 
Maple Grove, MN 

Overview

Jerry Molitor is a Rheumatologist practicing medicine in Maple Grove, Minnesota.

Dr. Molitor is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Dermatomyositis.

Dr. Molitor is board certified in Rheumatology: American Board Of Internal Medicine, 2001. He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 7 clinical trials. Dr. Molitor is currently accepting new patients.

Residency

University of Washington School of Medicine, Internal Medicine - 1997

Specialties

Rheumatology

Licenses

Internal Medicine in WA

Board Certifications

Rheumatology: American Board Of Internal Medicine, 2001

Fellowships

University of Washington School of Medicine, Rheumatology - 1999

Hospital Affiliations

M Health Fairview Woodwinds Hospital
M Health Fairview University Of Mn Medical Center
M Health Fairview Southdale Hospital
M Health Fairview Ridges Hospital

Languages Spoken

English
German

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avera Health
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Sanford Health
  • HMO
  • PPO
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

M Health Fairview Clinic Maple Grove
14500 99th Avenue North, Maple Grove, MN 55369
Other Locations
M Health Fairview Center for Lung Science and Health Clinic Minneapolis
909 Fulton Street Southeast, Suite 318, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: June 12, 2025
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
A Phase 2, Randomized, Placebo-controlled, Double-blind, Open-label Extension Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil (KD025) in Subjects With Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: August 30, 2023
Intervention Type: Drug
Study Drug: Belumosudil (KD025)
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Other, Biological, Drug, Diagnostic test
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
A Phase 2 Study to Evaluate Subcutaneous Abatacept vs. Placebo in Diffuse Cutaneous Systemic Sclerosis- a Double-blind, Placebo-controlled, Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: February 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

31 Total Publications

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.
Journal: Arthritis care & research
Published: November 21, 2025
Similar Doctors
Expertise in
3
conditions
Dr. John Schousboe
Rheumatology
Expertise in
3
conditions
Dr. John Schousboe
Rheumatology
Referral may be required

Office

3800 Park Nicollet Blvd, 
Minneapolis, MN 
 (6.4 miles away)
952-993-3280
Languages Spoken:
English
See accepted insurances

John Schousboe is a Rheumatologist practicing medicine in Minneapolis, Minnesota. Dr. Schousboe is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Fractured Spine, Postmenopausal Osteoporosis, Osteotomy, and Hip Replacement.

Expertise in
4
conditions
Dr. Barbara Segal
Rheumatology
Expertise in
4
conditions
Dr. Barbara Segal
Rheumatology
Referral may be required

University Of Minnesota Masonic Children's Hospital

420 Delaware St SE, 
Minneapolis, MN 
 (0.4 miles away)
612-625-8690
Languages Spoken:
English
See accepted insurances

Barbara Segal is a Rheumatologist practicing medicine in Minneapolis, Minnesota. Dr. Segal is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Triple X Syndrome, and Arthritis.

Expertise in
37
conditions
Dr. Mayra Oberto
Rheumatology
Expertise in
37
conditions
Dr. Mayra Oberto
Rheumatology
Referral may be required

North Memorial Health Clinic - Blaine

4181 108th Ave NE, 
Blaine, MN 
 (13.9 miles away)
763-284-5100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mayra Oberto is a Rheumatologist practicing medicine in Blaine, Minnesota. Dr. Oberto is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Rheumatoid Arthritis (RA), Postmenopausal Osteoporosis, and Psoriasis.

Frequently Asked Questions about Dr. Jerry Molitor

How do I make an appointment with Dr. Jerry Molitor?

You can book an appointment with Dr. Jerry Molitor by calling their office at 651-326-7990. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jerry Molitor a top-rated expert for Systemic Sclerosis (SSc)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jerry Molitor is classified as an Elite expert for Systemic Sclerosis (SSc), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jerry Molitor specialize in?

While Dr. Jerry Molitor is a Rheumatology, they have specific expertise in Systemic Sclerosis (SSc), Scleroderma, and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Jerry Molitor participate in research or clinical trials?

Yes. Dr. Jerry Molitor has published 31 articles and abstracts on conditions like Systemic Sclerosis (SSc). You can view a list of Dr. Jerry Molitor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jerry Molitor accept my insurance?

Dr. Jerry Molitor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 651-326-7990 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Molitor's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile